‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
Will Immunotherapy Shift the Balance of Treatment for Borderline Resectable Stage III NSCLC Away from Surgery? (BMIC-014)
30
00:00:00
/ 00:07:02
30